Lia Meuthia Zaini

Lia Meuthia Zaini

Auto-generated profile, based on publicly available information

Lia Meuthia Zaini

Department of Ophthalmology, Zainoel Abidin Hospital/Faculty of Medicine, Universitas Syiah Kuala, Jl. Moh. Daud Beureuh No.108, Banda Aceh 24415, Indonesia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2025 in Journal of Ophthalmic and Vision Research
Verified
Journal Article
Open access
PDF file
LZLia Meuthia Zaini
Lia Meuthia Zaini
AKArief Kartasasmita
Arief Kartasasmita
TGTjahjono D Gondhowiardjo
Tjahjono D Gondhowiardjo
MSMaimun Syukri
Maimun Syukri
RLRonny Lesmana
Ronny Lesmana
Purpose: To assess the effect of empagliflozin on the expression of SGLT-2 and GLUT-1 in the chorioretina of streptozotocin-induced diabetic rats. Methods: An in vivo experimental study was performed on Wistar rats. After a 2-week adaptation period, the rats were allocated to one of four groups. The group allocations were as follows: (K1) negative control (no intervention); (K2) positive control injected with streptozotocin (STZ) without treatment; (K3) positive control injected with STZ and treated with metformin; and (K4) positive control injected with STZ and treated with empagliflozin. SGLT-2 and GLUT-1 expressions were examined using the Western blot technique.Results: SGLT-2 was expressed in the chorioretinal tissue of all groups; administration of SGLT-2 inhibitors could suppress its expression. The average band thickness indicated that SGLT-2 expression was higher in diabetic rats compared to rats with normal sugar levels. GLUT-1 expression was noticed in all groups based on the chorioretinal examination. It did not change in the metformin group, whereas the empagliflozin group showed a significant decrease in the GLUT-1 expression. Conclusion: Both metformin and empagliflozin suppress the expression of SGLT-2 and GLUT-1 in the chorioretina of diabetic rats. In comparison, empagliflozin seems to be more potent in reducing this expression.

1 January 2020 in Journal of Epidemiology and Public Health
Verified
Journal Article
Open access
PDF file
LZLia Meuthia Zaini
Lia Meuthia Zaini
SMSri Marlinda
Sri Marlinda
ABAnnisa Meivira Budiman
Annisa Meivira Budiman
Clinical Characteristics of Diabetic Retinopathy Patients in Eye Clinic of Zainoel Abidin General Hospital Banda Aceh, Indonesia

4 December 2023 in African Vision and Eye Health
Verified
Journal Article
Open access
PDF file
LZLia M. Zaini
Lia M. Zaini
AKArief Kartasasmita
Arief Kartasasmita
TGTjahjono D. Gondhowiardjo
Tjahjono D. Gondhowiardjo
MSMaimun Syukri
Maimun Syukri
PMPutri N. Mulya
Putri N. Mulya
Background: Diabetic retinopathy (DR) is a significant microvascular complication of diabetes mellitus, leading to vision impairment and blindness in working-age adults globally. Aim: To evaluate the knowledge, clinical characteristics and associated factors among diabetic retinopathy patients attending an ophthalmology clinic at a tertiary hospital in Aceh from May 2020 to May 2021. Setting: The study was conducted at Zainoel Abidin General Hospital, Banda Aceh, Indonesia. Methods: A prospective cross-sectional study using consecutive sampling was conducted. Data collection involved patient history, eye examinations, laboratory tests and administering a questionnaire to assess knowledge of diabetes and diabetic retinopathy. The data were analysed using descriptive statistics and binary logistic regression. Results: Out of 173 participants, 170 were included in the study. A significant proportion had visual acuity less than 6/60 (44.1%) and proliferative diabetic retinopathy (PDR) (52.6%) with macular oedema in 11.8%. Only seven (4.1%) patients had good knowledge of diabetes and 28 (16.5%) had good knowledge of DR. A total of 113 (66.5%) patients were aware that diabetes could affect the eye and positively associated with the sex (adjusted odds ratio [AOR]: 6.18, 95% confidence interval [CI]: 1.80–21.21, P = 0.004), educational level (AOR: 4.66, 95% CI: 1.31–16.51, P = 0.017) and type of DM (AOR: 5.30, 95% CI: 1.97–14.26, P = 0.001). Conclusion: The study revealed a high incidence of vision-threatening diabetic retinopathy (VTDR), including severe non-proliferative, proliferative and significant macular oedema cases. However, patients’ knowledge of their disease was very low. Contribution: This study crucial data to the Department of Health Authority for policy decision-making.

30 September 2025 in International Journal of Retina
Verified
Journal Article
Open access
PDF file
LZLia Meuthia Zaini
Lia Meuthia Zaini
PMPutri Nabillah Mulya
Putri Nabillah Mulya
Introduction: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organ systems, including the eyes. Hypertensive optic neuropathy is a rare but serious manifestation of SLE that may precede SLE diagnosis. This case highlights the early ocular involvement in a young patient with undiagnosed SLE. Case Report: A 21-year-old female presented to our ophthalmology clinic with blurry vision in both eyes, along with elevated blood pressure at 165/126 mmHg. Ophthalmic examination revealed visual acuity of 20/200 on both eyes, bilateral optic disc swelling, macular edema, flame-shaped hemorrhages, and cotton-wool spots. These findings are consistent with hypertensive optic neuropathy. The antihypertensive drugs were initiated and planned for intravitreal bevacizumab administration. The patient was referred to internal medicine. Laboratory tests and clinical findings indicated secondary hypertension, anemia, leukopenia, and thrombocytopenia. Immuno-serological testing confirmed a diagnosis of SLE. The patient was initiated on systemic immunosuppressive therapy. Eight weeks after the first visit, she showed significant improvement, with the resolution of macular edema and optic disc swelling. The patient’s visual acuity improved to 20/50 in the right eye (RE) and 20/20 in the left eye (LE). Discussion: Hypertension in SLE is multifactorial, involving endothelial dysfunction, kidney injury, immune activation, and autoantibodies. Hypertensive retinopathy progresses through three phases: vasoconstrictive, sclerotic, and exudative, characterized by arterial narrowing, structural vascular changes, and blood-retina barrier disruption, leading to macular edema and ischemia. Diagnosis is based on fundoscopic examination and Optical Coherence Tomography (OCT), while management focuses on blood pressure control, anti-VEGF therapy, and close monitoring to prevent further complications. Conclusion: Early detection and multidisciplinary management are crucial in preventing irreversible visual loss and systemic complications. Regular ophthalmic follow-up and blood pressure monitoring are essential in SLE management.

17 February 2026 in International Journal of Retina
Verified
Journal Article
Open access
CSCut Putri Samira
Cut Putri Samira
ENEnny Nilawati
Enny Nilawati
LZLia Meuthia Zaini
Lia Meuthia Zaini
DIDian Islami
Dian Islami
PMPutri Nabillah Mulya
Putri Nabillah Mulya
Introduction: Endophthalmitis is a rare but vision-threatening intraocular infection that requires prompt and appropriate antimicrobial therapy. The microbial spectrum and antibiotic resistance patterns vary by region, yet data from Aceh, Indonesia, are limited. This study aimed to analyze the microbial profile and antibiotic susceptibility patterns of endophthalmitis cases treated at a tertiary healthcare center in Aceh. Methods: A retrospective descriptive study was conducted using medical records of patients diagnosed with endophthalmitis at dr. Zainoel Abidin General Hospital, Banda Aceh, from January 2021 to December 2024. Data collected included demographics, predisposing factors, etiological classification, microbiological culture results, and antibiotic susceptibility profiles. Microbiological identification and susceptibility testing were performed using standard culture methods and the VITEK2 Compact system. Result: A total of 111 eyes with unilateral endophthalmitis were included. Exogenous endophthalmitis predominated (95.5%), with post–cataract surgery (36.0%), traumatic (29.7%), and keratitis-related (27.1%) cases being most common. The mean patient age was 52.7 ± 18.5 years, with male predominance (63%). Bacterial isolates were identified in 26 eyes (23.5%), with Gram-negative organisms accounting for 65.4%. Pseudomonas aeruginosa was the most frequently isolated pathogen (58.8%). Gentamicin showed the highest overall susceptibility (75.0%), while vancomycin demonstrated complete sensitivity against Gram-positive isolates. Conclusion: Endophthalmitis in Aceh is predominantly exogenous and commonly caused by Gram-negative bacteria, particularly Pseudomonas aeruginosa. Gentamicin demonstrated the highest in vitro activity, while vancomycin and ceftazidime remain key components of empirical intravitreal therapy to ensure broad antimicrobial coverage. These findings provide important local microbiological data to support evidence-based management of endophthalmitis.

27 December 2025 in The Indonesian Biomedical Journal
Verified
Journal Article
Open access
PDF file
MSMaimun Syukri
Maimun Syukri
LZLia Meuthia Zaini
Lia Meuthia Zaini
AKArief Kartasasmita
Arief Kartasasmita
TGTjahjono Darminto Gondhowiardjo
Tjahjono Darminto Gondhowiardjo
RLRonny Lesmana
Ronny Lesmana
PMPutri Nabillah Mulya
Putri Nabillah Mulya
BACKGROUND: Connective tissue growth factor (CTGF) plays a central role in fibrotic processes affecting both renal and retinal tissues in diabetes. Although sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to exert renoprotective and antifibrotic effects, their impact on CTGF expression in renal and retinal tissues has not been clearly established. This preliminary study was conducted to evaluate whether SGLT2 inhibitors (SGLT2i) could influence CTGF expression in the kidneys and eyes of diabetes-induced rats.METHODS: After two weeks of adaptation, 24 rats were randomized and distributed equally into four groups (n=6 each): 1) Healthy Control, healthy rats without diabetic induction; 2) Negative Control, diabetic rats induced with streptozotocin (STZ) without treatment; 3) Metformin Group, diabetic rats treated with metformin; and 4) SGLT2i Group, diabetic rats treated with empagliflozin. Following eight weeks of intervention, CTGF expression was analyzed by Western blot in renal tissue (right kidney) and chorioretinal tissue (right eye). Four samples per group yielded analyzable bands and were included in the final quantification.RESULTS: In renal tissue, CTGF levels (mean±SD) were highest in Negative Control Group (0.81±0.06). Both the Metformin Group (0.58±0.14) and SGLT2i Group (0.57±0.33) demonstrated a trend toward reduced CTGF expression. In chorioretinal tissue, CTGF values were relatively similar across groups (Healthy Control: 0.67±0.05; Negative Control: 0.63±0.12), with Metformin Group (0.61±0.12) and SGLT2i Group (0.64±0.22) showing a modest reduction trend.CONCLUSION: In diabetic rats, CTGF expression levels are markedly increased. Following treatment with metformin and SGLT2i, CTGF expression demonstrates a noticeable reduction trend.KEYWORDS: SGLT2 inhibitor, metformin, connective tissue growth factor, cellular communication network factor 2, renal, retina